Company intelligence / Profile preview

Greenphire

King of Prussia, Pennsylvania, United Statesgreenphire.com ↗

Ownership: Private
Development stage: Commercial

Overview

Greenphire does not conduct therapeutic development or have a drug pipeline. Its suite of commercialized platforms automates payments, travel logistics, budgeting, and participant engagement across global clinical trials. The company’s solutions are widely adopted by sponsors, CROs, and sites to improve efficiency and patient retention. Key metrics include over $5 billion in payments processed as of 2023, support for more than four million patients across over 80 countries, and partnerships with major industry players.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Florence HealthcareMerck & Co. / Lyft ride-share program expansion

Beyond the preview

Go deeper on Greenphire.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Greenphire.

Explore the full profile